These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9886874

  • 1. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [Abstract] [Full Text] [Related]

  • 2. Endothelin: role in hypertension.
    Schiffrin EL.
    Biol Res; 1998 Dec; 31(3):199-208. PubMed ID: 9830507
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL, Turgeon A, Deng LY.
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B, Oemar BS, Siebenmann R, von Segesser L, Lüscher TF.
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P.
    Scand Cardiovasc J Suppl; 1997 Mar; 46():1-40. PubMed ID: 9265559
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endothelin: role in experimental hypertension.
    Schiffrin EL.
    J Cardiovasc Pharmacol; 2000 Mar; 35(4 Suppl 2):S33-35. PubMed ID: 10976778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
    Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M.
    Circulation; 1995 Feb 15; 91(4):1229-35. PubMed ID: 7850963
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug 15; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional characterization of endothelin receptors in hypertensive resistance vessels.
    Montagnani M, Potenza MA, Rinaldi R, Mansi G, Nacci C, Serio M, Vulpis V, Pirrelli A, Mitolo-Chieppa D.
    J Hypertens; 1999 Jan 15; 17(1):45-52. PubMed ID: 10100093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.